Why NeuroMetrix (NURO) Stock Is Surging Today

NEW YORK (TheStreet) -- NeuroMetrix  (NURO) surged Tuesday after the medical technology developer reported Japanese regulatory approval for NC-stat DPNCheck.

The company announced it had received marketing certification from Technischer Uberwachungs-Verein SUD Japan for NC-stat DPNCheck as a Class II Designated Controlled Medical Device based on the technical standards of the Japan Ministry of Health, Labor, and Welfare. NC-stat DPNCheck is a test designed to detect diabetic peripheral neuropathy, or DPN, at an early stage.

Omron Healthcare is the exclusive distributor for NeuroMetrix in Japan and will distribute NC-stat DPNCheck in the nation.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The stock was up 26% to $2.37 at 12:19 p.m. More than 1.8 million shares had changed hands, which dwarfed the average volume of 62,722.

NURO Chart

NURO data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers